Typical ENT disorders include cholesteatoma, dizziness, dysphagia (difficulty swallowing), ear infection (otitis media), gastric reflux, hearing aids, and hearing loss.
ENT Surgical Navigation System Market: Introduction
- Typical ENT disorders include cholesteatoma, dizziness, dysphagia (difficulty swallowing), ear infection (otitis media), gastric reflux, hearing aids, and hearing loss. Many diseases among these require surgical treatment. Surgical navigation systems include utilization of imaging modalities during the surgical procedure, thereby enabling minimally invasive surgery. ENT surgical navigation system is designed to provide improved intraoperative feedback and alignment validation to surgeons during surgical procedures.
Read Report Overview - https://www.transparencymarketresearch.com/ent-surgical-navigation-system-market.html
- Many manufacturers are investing resources to develop technologically advanced surgical navigation systems to offer more precise outcomes. Stryker’s Scopis TGS is a next-generation solution for navigated Functional Endoscopic Sinus Surgery (FESS) that offers surgeons highly advanced image guidance and visualization capabilities in a single system. Excelim-04, which is the product of Heal Force, is an infrared-laser guided tracking system used to track 3D position and orientation of active or passive markers attached to surgical tools with advanced optical measurement technology that delivers exceptional accuracy (spatial resolution 1.0mm) and reliability.
Key Drivers and Restraints of Global ENT Surgical Navigation System Market
- Rise in prevalence of ENT disorders are boosting the market growth. Diseases of auditory system (57.84%) were the most common groups of ENT problems among the pediatric population, followed by pharyngo-esophageal (23.53%) and nasal disorders (18.63%). According to an article published in iMedPub LTD in 2018, the prevalence of dysphagia, which is also one of the common ENT disorders, in the general population was 16%–23%, which is expected to increase to 27% in those over 76 years of age. As per the American Academy of Sleep Medicine, 50 to 70 million adults in the U.S. people suffer from sleep apnea.
Request a PDF Brochure - https://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=77004
- However, product recall of ENT surgical navigation systems may hamper the market. In 2017, FDA recalled Medtronic ENT surgical navigation system StealthStation AxiEM. In 2014, Stryker NAV3i Platform got recalled by FDA. This Navigation system is used in combination with surgical software for cranial, spine, ENT, orthopedic, and trauma procedures.
Electromagnetic to Dominate Global ENT Surgical Navigation System Market
- Based on technology, the global ENT surgical navigation system market can be divided into electromagnetic navigation systems, optical navigation systems, and hybrid navigation systems
- Optical navigation system is expected to grow at the highest CAGR during the forecast period of 2020 to 2030. This is due to the advantage that optical navigation system offers over electromagnetic navigation technology including reduced radiation exposure and accuracy provided during complex surgeries.
- However, electromagnetic navigation systems dominated the global ENT surgical navigation system market in 2019 in terms of revenue generation. In 2017, Medtronic launched a new surgical navigation system based on electromagnetic (EM) tracking technology, StealthStation ENT for surgeons treating conditions within the ear, nose, and throat (ENT) anatomy.
Request for Analysis of COVID19 Impact on ENT Surgical Navigation System Market - https://www.transparencymarketresearch.com/sample/sample.php?flag=covid19&rep_id=77004
Ambulatory Surgical Centers Segment Witness Highest Growth
- Based on end-user, the global ENT surgical navigation system market can be divided into hospitals, specialty clinics, ambulatory surgical centers, and physician practices
- In 2019, the hospitals segment dominated the ENT surgical navigation system market in terms of highest revenue generation and is anticipated to continue leading the market over the forecast period. This is due to extensive use of technologically advanced medical devices to offer point-of-care (PoC). Furthermore, greater number of patients undergoing treatments in hospitals and implementation of government initiatives for installing surgical navigation systems in hospitals boost the segment growth.
- However, the ambulatory surgical centers segment is expected to grow at the highest CAGR during the forecast period, owing to rise in adoption of ASC in developing countries and shortage of hospital beds
Enquiry Before Buying - https://www.transparencymarketresearch.com/sample/sample.php?flag=EB&rep_id=77004
North America to Dominate Global ENT Surgical Navigation System Market
- In terms of region, the global ENT surgical navigation system market can be divided into: North America, Europe, Asia Pacific, Latin America, and Middle East & Africa
- In terms of revenue, North America dominated the ENT surgical navigation system market, followed by Europe. However, Asia Pacific is experienced to grow at the highest CAGR during the forecast period of 2020 to 2030, due to rise in number of ENT disorders and ENT surgeries performed in the emerging countries.
- According to the WHO, approximately one third of people over 65 years of age are affected by disabling hearing loss. The prevalence of hearing loss in this age group is greatest in South Asia, Asia Pacific, and sub-Saharan Africa. In China, 27.8 million people have disabling hearing loss, accounting for 33.5% of the total registered disabled as per an article published in BioMed Central Ltd in 2019.
Key Manufacturers Operating in Market
The global ENT surgical navigation system market was highly fragmented in 2018. Key manufacturers operating in the global market are:
- Brainlab AG
- ClaroNav
- Collin Medical
- Heal Force
- Medtronic
- NDI
- Scopis
- Shenzhen Anke High-Tech
- Stryker
Browse more Reports by Transparency Market Research:
Plasma Fractionation Market: Rising indications and therapeutic usage of plasma-derived proteins is an important factor that is expected to boost the plasma fractionation market during the forecast period. Rise in the geriatric population and the demand for plasma proteins is anticipated to drive the demand for plasma fractionation during the forecast period.
CRISPR and Cas Genes Market: The use of CRISPR-Cas systems in bacterial activities, increase in research and development expenditure by governments in the fields of genome editing, rise in the presence of genetic diseases, and the use of CRISPR technology to advance crop production have been the key drivers of the CRISPR and Cas genes market worldwide.
About Us
Transparency Market Research is a next-generation market intelligence provider, offering fact-based solutions to business leaders, consultants, and strategy professionals.
Our reports are single-point solutions for businesses to grow, evolve, and mature. Our real-time data collection methods along with ability to track more than one million high growth niche products are aligned with your aims. The detailed and proprietary statistical models used by our analysts offer insights for making right decision in the shortest span of time. For organizations that require specific but comprehensive information we offer customized solutions through ad hoc reports. These requests are delivered with the perfect combination of right sense of fact-oriented problem solving methodologies and leveraging existing data repositories.
TMR believes that unison of solutions for clients-specific problems with right methodology of research is the key to help enterprises reach right decision.
Contact
Mr. Rohit Bhisey
Transparency Market Research
State Tower,
90 State Street,
Suite 700,
Albany NY - 12207
United States
USA - Canada Toll Free: 866-552-3453